相关实验视频
Updated: Jan 9, 2026

08:36
Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3
Published on: April 7, 2023
1.5K
用abrocitinib成功治疗耐火侵蚀性平坦:一个病例报告
Valerie Hladky1,2, Deana Funaro1,2, Rosalie-Sélène Meunier1,3
1Faculty of Medicine, Université de Montréal, QC, Canada.
SAGE open medical case reports
|December 1, 2025
概括
侵蚀性平坦,一种严重的自身免疫性疾病,通常会抵抗治疗. 选择性Janus激酶1抑制剂abrocitinib在耐火病例中成功实现了完全缓解,为患者提供了新的希望.
科学领域:
- 免疫学 免疫学 免疫学
- 皮肤病学 皮肤病学
- 胃肠病学 胃肠病学
背景情况:
- 侵蚀性平淡是一种罕见的,慢性,免疫介导的炎症性疾病.
- 它经常导致显著的发病率,并且通常对传统疗法具有抗性.
- 自发缓解在侵蚀性平坦中不常见.
研究的目的:
- 报告一个严重的,耐火侵蚀性平坦的病例.
- 为了评估abrocitinib在治疗耐药的患者中的疗效.
- 为了突出一种潜在的新疗法选择侵蚀性平坦.
主要方法:
- 一个62岁的妇女的病例报告,患有严重的侵蚀性平坦.
- 患者的口腔,生殖器和食道粘膜都受到影响.
- 开始治疗abrocitinib,一个选择性的Janus激酶1抑制剂.
主要成果:
- 这位患者之前多次系统性治疗都失败了.
- 阿布罗西替尼治疗导致了完全和持续的临床缓解.
- 这表明对向治疗的积极反应.
结论:
- 阿布罗西替尼在治疗严重,耐火性侵蚀性平坦的治疗中显示出潜在的有效性.
- 向的Janus激酶1抑制可能提供一种新的治疗策略.
- 需要进一步的研究,以探索abrocitinib在侵蚀性平坦菌管理中的作用.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
413
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
413
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
461
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
461
